Search

Search

Home
...
Research Domains Biomedical and Clinical Sciences Oncology and Carcinogenesis Predictive and prognostic markers
Research Domains
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Predictive and prognostic markers
[Clinical Applications of Circulating Tumor DNA in Response Evaluation and Relapse Monitoring of Primary Mediastinal Large B-Cell Lymphoma]

[Clinical Applications of Circulating Tumor DNA in Response Evaluation and Relapse Monitoring of Primary Mediastinal Large B-Cell Lymphoma]

Lu Pan ^1,2, Xin-Miao Jiang ², Yan Teng ^1,2, Ning Wang ^1,2, Ling Huang ², Han-Guo Guo ², Si-Chu Liu ², Xiao-Juan Wei ², Fei-Li Chen ², Zhan-Li Liang ², Wen-Yu Li ^1,2

Lu Pan ^1,2, Xin-Miao Jiang ², Yan Teng ^1,2

¹School of Medicine of South China University of Technology, Guangzhou 510006, Guangdong Province, China.
²Department of Lymphoma, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, Guangdong Province, China.

⁰School of Medicine of South China University of Technology, Guangzhou 510006, Guangdong Province, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi +

|

May 6, 2025

|

May 6, 2025

Related Experiment Videos

Contact us if these videos are not relevant.

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

See all related videos

View abstract on PubMed

Summary

This summary is machine-generated.

Circulating tumor DNA (ctDNA) shows promise in evaluating treatment response and monitoring relapse in primary mediastinal large B-cell lymphoma (PMBCL). Combining ctDNA with PET/CT may improve patient management and outcomes.

Area Of Science

Oncology
Hematology
Molecular Diagnostics

Keywords:

primary mediastinal large B-cell lymphoma; circulating tumor DNA; PET/CT; efficacy evaluation; relapse monitoring

Related Experiment Videos

Contact us if these videos are not relevant.

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

See all related videos

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies